[144] Eos Energy Enterprises, Inc. SEC Filing

Rhea-AI Filing Summary

Eos Energy Enterprises (EOSE) reported a proposed sale of 50,000 common shares through UBS Financial Services with an aggregate market value of $395,091. The shares represent previously vested restricted stock units acquired on 06/15/2021 (5,198 shares), 05/15/2023 (10,600 shares) and 05/14/2025 (34,202 shares). The seller plans the transaction on or about 09/03/2025 on Nasdaq. The filing shows no sales by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Full disclosure of acquisition history showing RSU vesting dates and amounts
• Broker and planned sale date provided, enabling market transparency
• No reported sales in the prior three months for the same account

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale of vested RSUs; size is immaterial relative to outstanding shares.

The notice documents a planned sale of 50,000 shares acquired via RSU vesting across three dates, executed through UBS on Nasdaq. At an aggregate value of $395,091, the transaction is small relative to the issuer's reported 259,853,606 shares outstanding, indicating limited direct market impact. No prior sales in the past three months are reported for the same account, which reduces concerns about a pattern of disposal. The filing is procedural and provides required assurances about material nonpublic information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure consistent with Rule 144; the filing meets standard insider-sale requirements.

The Form 144 discloses the broker, planned sale date, and the acquisition history of the securities (RSU vesting). This transparency aligns with Rule 144 obligations for reporting proposed sales by persons covered under the rule. The signer affirms no undisclosed material adverse information, and the absence of recent sales simplifies aggregation rules. From a governance standpoint, the filing appears complete for its purpose, with no governance red flags presented in the text.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	50000	395091	259853606	09/03/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/15/2021	RSU Vesting	Issuer			5198	06/15/2021	N/A
Common	05/15/2023	RSU Vesting	Issuer			10600	05/15/2023	N/A
Common	05/14/2025	RSU Vesting	Issuer			34202	05/14/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does EOSE's Form 144 disclose about the planned sale?

It discloses a proposed sale of 50,000 common shares through UBS with an aggregate market value of $395,091 planned for 09/03/2025.

How were the 50,000 EOSE shares acquired?

All shares were acquired via RSU vesting on 06/15/2021 (5,198), 05/15/2023 (10,600) and 05/14/2025 (34,202).

Does the filing report recent sales by the same person?

The filing states Nothing to Report for securities sold during the past three months.

On which exchange will the EOSE shares be sold?

The planned sale is to occur on Nasdaq through UBS Financial Services.

Is there any assertion about undisclosed material information in the Form 144?

Yes, the signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.